Scientific article| Volume 35, ISSUE 1, P104-108, January 2010

Mycobacterial Hand Infections Occurring Postoperatively in Patients Treated With Tumor Necrosis Factor-α Inhibitors for Inflammatory Arthritis: Report of Three Cases

      Tumor necrosis factor-α inhibitors are potent anti-rheumatic drugs, but there is evidence that the high level of immunosuppression they provide may also lead to a higher risk of infections. At our institution, 3 patients with inflammatory arthritis treated with tumor necrosis factor-α inhibitors developed mycobacterial soft tissue infections after routine hand surgery. All 3 patients required multiple surgical procedures, inpatient hospitalizations, and prolonged antibiotic multidrug therapy to clear the infections.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grennan D.M.
        • Gray J.
        • Loudon J.
        • Fear S.
        Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery.
        Ann Rheum Dis. 2001; 60: 214-217
        • Sany J.
        • Anaya J.M.
        • Canovas F.
        • Combe B.
        • Jorgensen C.
        • Saker S.
        • et al.
        Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis.
        J Rheumatol. 1993; 20: 1129-1132
        • Jain A.
        • Harley O.
        • Patel R.M.
        • Nanchahal J.
        Survey on the perioperative use of TNF-α inhibitors in rheumatoid hand surgery.
        J Hand Surg. 2006; 31B: 463-464
        • Pappas D.A.
        • Giles J.T.
        Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections?.
        Curr Opin Rheumatol. 2008; 20: 450-456
        • Schett G.
        • Stach C.
        • Zwerina J.
        • Voll R.
        • Manger B.
        How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
        Arthritis Rheum. 2008; 58: 2936-2948
        • Bongartz T.
        • Sutton A.J.
        • Sweeting M.J.
        • Buchan I.
        • Matteson E.L.
        • Montori V.
        Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
        JAMA. 2006; 295: 2275-2285
        • Doran M.F.
        • Crowson C.S.
        • Pond G.R.
        • O'Fallon W.M.
        • Gabriel S.E.
        Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.
        Arthritis Rheum. 2002; 46: 2287-2293
        • Wilson M.G.
        • Kelley K.
        • Thornhill T.S.
        Infection as a complication of total knee replacement arthroplasty: risk factors and treatment in sixty-seven cases.
        J Bone Joint Surg. 1990; 72A: 878-883
        • Curtis J.R.
        • Patkar N.
        • Xie A.
        • Martin C.
        • Allison J.J.
        • Saag M.
        • et al.
        Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.
        Arthritis Rheum. 2007; 56: 1125-1133
        • Salvana E.M.
        • Cooper G.S.
        • Salata R.A.
        Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients.
        J Infect. 2007; 55: 484-487
        • den Broeder A.A.
        • Creemers M.G.
        • Fransen J.
        • de Jong E.
        • de Rooij D.J.
        • Wymenga A.
        • et al.
        Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for antitumor necrosis factor: a large retrospective study.
        J Rheumatol. 2007; 34: 689-695
        • Mori R.
        • Kondo T.
        • Ohshima T.
        • Ishida Y.
        • Mukaida N.
        Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration.
        FASEB J. 2002; 16: 963-974
        • Kozin S.H.
        • Bishop A.T.
        Atypical mycobacterium infections of the upper extremity.
        J Hand Surg. 1994; 19A: 480-487
        • Fodero J.
        • Chung K.C.
        • Ognenovski V.M.
        Flexor tenosynovitis in the hand caused by Mycobacterium terrae.
        Ann Plast Surg. 1999; 42: 330-332
        • Whitehouse J.D.
        • Friedman N.D.
        • Kirkland K.B.
        • Richardson W.J.
        • Sexton D.J.
        The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost.
        Infect Control Hosp Epidemiol. 2002; 23: 183-189